Supporting Adolescents to Adhere - an Intervention Using Airtime Rewards Allocated by a Prize Drawing (SATA)
Human Immunodeficiency Virus
About this trial
This is an interventional treatment trial for Human Immunodeficiency Virus focused on measuring HIV, Antiretroviral (ARV), co-trimoxazole, SMS, Lottery incentive, mobile health, Uganda, Youth
Eligibility Criteria
Inclusion Criteria:
- have been in HIV care at the clinic for at least three months
- are currently taking HIV-related medication (ART or co-trimoxazole)
- either own a phone or have regular access to one
- intend to stay at the clinic for the study period
- are not in boarding school (where phones are forbidden)
Exclusion Criteria:
- does not speak or understand either English or Luganda
Sites / Locations
- Mildmay Uganda
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Active Comparator
Own Adherence Group
Fixed Adherence Group
Control Group
Participant chooses their adherence level to be reached at next clinic visit (at least 80%, but can be higher). If they reach that percentage measured using the MEMS cap, they can participate in a lottery for an airtime reward of none, a small amount, and a larger amount. Participants also receive a weekly motivational message reminding them of their incentive to adhere. If they respond to the message they will receive airtime top-up.
Participant is told to meet a pre-determined target of 90%. If they reach that percentage measured using the MEMS cap, they can participate in a lottery for an airtime reward of none, a small amount, and a larger amount. Participants also receive a weekly motivational message reminding them of their incentive to adhere. If they respond to the message they will receive airtime top-up.
Participants do not receive a lottery incentive conditional on adherence. Participants will however, continue to receive weekly messaging with airtime top-up contingent on response.